- Youth hardest hit by COVID-19 Read More
- Branding key to selling Bajan and Caribbean products, says Caddle Read More
- Four more footballers have COVID Read More
- Williams ready to ride again Read More
- Wanted: A more efficient airport Read More
- Low-hanging fruit for all Read More
- Avatar sequel to resume filming in New Zealand Read More
KINSHASA – Health authorities in Democratic Republic of Congo will introduce a Johnson & Johnson (J&J) Ebola vaccine in November in the country’s eastern provinces, to counter the current outbreak, they said.
The J&J vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225 000 people.
It requires two injections eight weeks apart, unlike the Merck vaccine, which requires a single shot.
A first batch of 500 000 doses of the J&J vaccine should arrive in Congo next week, the authorities said in a statement. The inoculation process will start in Goma in early November and then be extended to other provinces.
Congolese health authorities had announced the deployment of the vaccine last month, but had not specified when the campaign will take place.
Since it first started in August 2018, the Ebola outbreak has killed more than 2 100 people, second only to the 2013 to 2016 outbreak in West Africa that killed more than 11 300. (Reuters)